DICP OpenIR
Identification of CYP isoforms involved in the metabolism of thymol and carvacrol in human liver microsomes (HLMs)
Dong, Rui-Hua1; Fang, Zhong-Ze2,3; Zhu, Liang-Liang2; Ge, Guang-Bo2; Cao, Yun-Feng2; Li, Xiao-Bao4; Hu, Cui-Min; Yang, Ling2; Liu, Ze-Yuan1
刊名PHARMAZIE
2012-12-01
DOI10.1691/ph.2012.2534
67期:12页:1002-1006
收录类别SCI
文章类型Article
WOS标题词Science & Technology ; Life Sciences & Biomedicine ; Physical Sciences
类目[WOS]Chemistry, Medicinal ; Chemistry, Multidisciplinary ; Pharmacology & Pharmacy
研究领域[WOS]Pharmacology & Pharmacy ; Chemistry
关键词[WOS]CYTOCHROME-P450 ENZYMES ; DRUG INTERACTIONS ; INHIBITION ; EXPRESSION ; POPULATION ; MODEL
英文摘要Carvacrol and thymol are phenolic compounds with similar structures isolated from many aromatic plants, and have been demonstrated to exert multiple pharmacological effects. The metabolic and pharmacokinetic behaviour of thymol and carvacrol has received much attention. Carvacrol and thymol have been demonstrated to undergo phase I metabolism such as hydroxylation reaction. However, drug-metabolizing enzymes involved in this process remain unclear. Given that cytochrome P450 s (CYPs) are involved in most phase I metabolism, the aim of the present study was to investigate the role of CYPs in the metabolism of thymol and carvacrol. After incubation with human liver microsomes (HLMs) in the presence of NADPH, a new metabolite and two metabolites were detected for thymol and carvacrol, respectively. A combination of chemical inhibition studies and assays with recombinant CYP isoforms demonstrated that CYP2A6 was the predominant drug-metabolizing enzyme involved in the metabolism of thymol and carvacrol. All these results remind the researchers that special attention should be paid on pharmacokinetic and clinical outcomes when thymol or carvacrol was co-administrated with other compounds mainly undergoing CYP2A6-mediated metabolism.
语种英语
WOS记录号WOS:000311883800008
引用统计
文献类型期刊论文
条目标识符http://cas-ir.dicp.ac.cn/handle/321008/143107
专题中国科学院大连化学物理研究所
作者单位1.Acad Mil Med Sci, Affiliated Hosp, Dept Clin Pharmacol, Beijing 100071, Peoples R China
2.Chinese Acad Sci, Dalian Inst Chem Phys, Lab Pharmaceut Resource Discovery, Dalian, Peoples R China
3.NCI, Lab Metab, Ctr Canc Res, Bethesda, MD 20892 USA
4.Acad Mil Med Sci, Affiliated Hosp, Dept Breathing Gastroenterol, Beijing 100071, Peoples R China
推荐引用方式
GB/T 7714
Dong, Rui-Hua,Fang, Zhong-Ze,Zhu, Liang-Liang,et al. Identification of CYP isoforms involved in the metabolism of thymol and carvacrol in human liver microsomes (HLMs)[J]. PHARMAZIE,2012,67(12):1002-1006.
APA Dong, Rui-Hua.,Fang, Zhong-Ze.,Zhu, Liang-Liang.,Ge, Guang-Bo.,Cao, Yun-Feng.,...&Liu, Ze-Yuan.(2012).Identification of CYP isoforms involved in the metabolism of thymol and carvacrol in human liver microsomes (HLMs).PHARMAZIE,67(12),1002-1006.
MLA Dong, Rui-Hua,et al."Identification of CYP isoforms involved in the metabolism of thymol and carvacrol in human liver microsomes (HLMs)".PHARMAZIE 67.12(2012):1002-1006.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Dong, Rui-Hua]的文章
[Fang, Zhong-Ze]的文章
[Zhu, Liang-Liang]的文章
百度学术
百度学术中相似的文章
[Dong, Rui-Hua]的文章
[Fang, Zhong-Ze]的文章
[Zhu, Liang-Liang]的文章
必应学术
必应学术中相似的文章
[Dong, Rui-Hua]的文章
[Fang, Zhong-Ze]的文章
[Zhu, Liang-Liang]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。